No definition available.
Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
C3_PAROTIDGLAND_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
336 |
4. Check minimum number of eventsNone |
336 |
5. Include endpointsNone |
336 |
6. Filter based on genotype QC (FinnGen only) |
336 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 336 | 155 | 181 |
| Unadjusted period prevalence (%) | 0.07 | 0.05 | 0.08 |
| Median age at first event (years) | 61.79 | 58.74 | 64.39 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 249
- Matched controls
- 2491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
+∞
169.9
143
*
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
199.3
159.8
154
20
ELB50
NOMESCO Finland
Total parotidectomy
1545.0
106.5
96
*
ELB40
NOMESCO Finland
Partial parotidectomy
180.9
99.8
99
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
63.3
58
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
32.1
59.9
80
36
130
Kela drug reimbursment
Malignant tumour
+∞
54.2
50
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
49.7
46
*
8550/3-C07.9
ICD-O-3
Acinar cell carcinoma of parotid gland
+∞
43.0
40
*
C07.71
ICD-10 Finland
Malignant tumor in the deep part of the parotid gland
+∞
40.8
38
*
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
237.0
40.1
40
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
37.4
35
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.6
34.4
83
137
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
135.1
33.6
35
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
30.9
29
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
5.3
30.0
116
350
8430/3-C07.9
ICD-O-3
Mucoepidermoid carcinoma of parotid gland
+∞
29.8
28
*
WF002
NOMESCO Finland
Radical radiotherapy
163.3
28.3
29
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
15.4
28.1
47
37
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
17.7
27.2
43
29
WX408
NOMESCO Finland
General anesthesy, balanced
4.7
25.9
113
374
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
25.4
24
*
C08.89
ICD-10 Finland
Malignant overall tumor the large salivary glands anna or unspecified histology
+∞
25.4
24
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.2
25.2
49
53
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
24.4
23
*
H02AB02
ATC
dexamethasone; systemic
35.1
24.4
31
10
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
+∞
23.3
22
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
25.1
22.3
31
14
8070/3-C07.9
ICD-O-3
Squamous cell carcinoma, NOS, of parotid gland
+∞
22.2
21
*
8500/3-C07.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of parotid gland
+∞
21.1
20
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
21.1
20
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
21.1
20
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
21.1
20
*
C07
ICD-10 Finland
Malignant neoplasm of parotid gland
+∞
20.1
19
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
114.2
19.9
21
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
19.0
18
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
19.0
18
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
17.9
17
*
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
17.9
17
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
45.7
17.6
21
5
G51.0
ICD-10 Finland
Bell palsy
13.5
17.4
30
25
C08.99
ICD-10 Finland
Malignant tumor of unspecified large salivary gland, other or unspecified histology
+∞
16.9
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.9
16
*
8200/3-C07.9
ICD-O-3
Adenoid cystic carcinoma of parotid gland
+∞
16.9
16
*
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
96.7
16.8
18
*
JN4BD
NOMESCO Finland
Extensive body CT
8.1
16.6
38
54
R4190
NOMESCO Finland
Nutritional therapy
26.6
16.3
22
9
A04AA01
ATC
ondansetron; systemic, rectal
16.5
15.2
24
16
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
85.3
14.7
16
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
14.7
14
*
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
14.7
14
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
14.7
14
*
WX402
NOMESCO Finland
General anaesthesia
4.6
14.7
54
140
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
15.7
14.4
23
16
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
79.6
13.7
15
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
79.6
13.7
15
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
13.7
13
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
147.7
13.6
14
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
13.2
13.4
23
19
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
12.6
12
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
12.6
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
11.9
12.3
22
20
L03AA02
ATC
filgrastim; parenteral
68.3
11.7
13
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.2
11.7
28
43
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.5
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
8140/3-C07.9
ICD-O-3
Adenocarcinoma, NOS, of parotid gland
+∞
11.5
11
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
11.5
11
*
8562/3-C07.9
ICD-O-3
Epithelial-myoepithelial carcinoma of parotid gland
+∞
11.5
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
125.6
11.5
12
*
XW000
NOMESCO Finland
Bone marrow biopsy
9.2
10.8
22
26
A07AA02
ATC
nystatin; oral
5.6
10.6
31
62
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
114.6
10.5
11
*
H02.2
ICD-10 Finland
Lagophthalmos
114.6
10.5
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
114.6
10.5
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
2.5
10.5
108
577
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
C08.94
ICD-10 Finland
Mucoepidermoid carcinoma of an unspecified large salivary gland
+∞
10.5
10
*
WX110
NOMESCO Finland
Local anesthesy
2.5
10.4
173
1186
Z51.5
ICD-10 Finland
Palliative care
10.7
10.2
19
19
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
41.9
10.1
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
10.0
118
670
S04
ICPC
Lump/swelling localized
4.3
10.0
37
96
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
9.5
112
632
AAH50
NOMESCO Finland
Cranial nerve anastomosis
103.8
9.5
10
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
103.8
9.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
103.8
9.5
10
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
22.7
9.4
13
6
L02BB03
ATC
bicalutamide; oral
+∞
9.4
9
*
9691/3-C07.9
ICD-O-3
Follicular lymphoma, grade 2 of parotid gland
+∞
9.4
9
*
8010/3-C07.9
ICD-O-3
Carcinoma, NOS, of parotid gland
+∞
9.4
9
*
9680/3-C07.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of parotid gland
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
115
Kela drug reimbursment
Breast cancer
+∞
9.4
9
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.4
9
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
9.4
9
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
9.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
9591/3-C07.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of parotid gland
+∞
9.4
9
*
PJD91
NOMESCO Finland
Excision of lymph nodes in neck, 1 to 2 areas in total
+∞
9.4
9
*
UDC00
NOMESCO Finland
Ear microscopy
4.4
9.4
34
86
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
6.7
9.3
23
37
CBF10
NOMESCO Finland
Shortening of canthal ligaments and tarsal plate for ectropion
51.9
8.7
10
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.8
8.7
24
45
ED1AA
NOMESCO Finland
Mandipular X-ray examination
28.6
8.6
11
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
93.1
8.5
9
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
93.1
8.5
9
*
N02AA05
ATC
oxycodone; systemic
3.2
8.4
46
163
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
EP1BG
NOMESCO Finland
MRI examination of soft tissue of neck with high intesity magnet
+∞
8.4
8
*
8941/3-C07.9
ICD-O-3
Carcinoma ex pleomorphic adenoma of parotid gland
+∞
8.4
8
*
EBA10
NOMESCO Finland
Surgical removal of tooth
3.7
8.2
36
109
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.3
8.2
42
144
ZXA00
NOMESCO Finland
Right side
2.4
7.9
83
436
EL3AE
NOMESCO Finland
Salivary gland ultrasound examination
15.7
7.8
12
8
4405
FHL
Partial removal of the parotid gland
46.5
7.8
9
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
8.5
7.7
16
20
WZC30
NOMESCO Finland
Teaching
3.5
7.7
36
115
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
19.1
7.7
11
6
ZXA05
NOMESCO Finland
Left side
2.4
7.7
78
402
K05.30
ICD-10 Finland
Periodontitis complex
3.1
7.5
42
152
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
82.4
7.5
8
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
82.4
7.5
8
*
S18
ICPC
Laceration/cut
2.1
7.4
111
681
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
8502/3-C07.9
ICD-O-3
Secretory carcinoma of parotid gland
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
ELB60
NOMESCO Finland
Radical parotidectomy sacrificing the facial nerve
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
8147/3-C07.9
ICD-O-3
Basal cell adenocarcinoma of parotid gland
+∞
7.3
7
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
7.3
7
*
SCA04
NOMESCO Finland
Guidance on care of mouth and oral mucosa
+∞
7.3
7
*
4404
FHL
Complete removal of the parotid gland
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
+∞
7.3
7
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.0
6.9
21
45
H02.1
ICD-10 Finland
Ectropion of eyelid
17.3
6.8
10
6
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
41.2
6.8
8
*
ZZR00
NOMESCO Finland
Flap of skin
23.2
6.7
9
*
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
12.7
6.6
11
9
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
12.7
6.6
11
9
H60.4
ICD-10 Finland
Cholesteatoma of external ear
71.6
6.5
7
*
UJC01
NOMESCO Finland
Scopy of lower throat
14.8
6.4
10
7
DFF00
NOMESCO Finland
Pure tone audiometry
3.3
6.4
31
102
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
6.4
67
348
L02AE02
ATC
leuprorelin; implant, parenteral
18.6
6.3
9
5
L01BC06
ATC
capecitabine; oral
+∞
6.3
6
*
C08.90
ICD-10 Finland
Malignant tumor in unspecified large salivary gland without histology
+∞
6.3
6
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
6.3
6
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
6.3
6
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
6.3
6
*
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
27.4
6.3
8
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
27.4
6.3
8
*
JN4AD
NOMESCO Finland
Body CT examination
5.8
6.1
16
29
K11.2
ICD-10 Finland
Sialoadenitis
6.3
6.1
15
25
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
10.4
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
107
33
47.11
173.08
1.4
1.3
—
—
—
0
0
225
1343
3.04
20.63
12.2
6.3
3.7
4.3
e9/l
4.10
200
1174
63
194
3.77
17.88
1.8
1.8
0.2
0.2
g/l
3.86
63
170
114
540
2.68
15.27
2.5
1.9
—
—
—
0
0
66
247
3.08
13.57
6.6
2.9
229.9
236.4
u/l
0.28
66
232
177
1080
2.35
13.25
3.8
3.6
—
—
—
0
0
144
805
2.38
13.18
6.0
2.1
2.3
2.4
mmol/l
0.30
135
673
41
124
3.63
11.79
3.4
1.4
22.4
4.9
ug/l
0.76
33
96
176
1114
2.22
11.56
6.4
4.9
1.2
1.2
mmol/l
1.52
163
994
259
1932
2.49
11.31
9.9
5.3
82.3
75.8
u/l
1.22
243
1767
80
364
2.57
11.25
3.5
2.6
0.8
0.8
mmol/l
1.80
73
334
186
1222
2.17
10.90
7.4
5.6
1.2
1.2
mmol/l
0.50
161
1047
167
1082
2.08
9.82
6.0
3.5
35.2
35.5
g/l
0.36
153
1004
9
9
10.23
5.05
1.0
1.1
—
—
—
0
0
25
94
2.79
5.04
1.2
1.3
2.7
3.1
g/l
1.48
20
72
25
98
2.68
4.67
1.2
1.3
—
—
—
0
0
25
98
2.68
4.67
1.2
1.3
3.4
3.9
g/l
1.12
19
70
289
2595
1.81
3.56
19.3
12.6
25.9
22.9
mg/l
0.87
241
1990
36
194
1.96
3.26
3.6
1.9
61.4
63.4
ml/min/173m2
0.10
15
77
18
73
2.55
3.18
1.5
1.3
—
1.1
—
0
11
187
1540
1.48
3.14
4.9
4.1
6.7
6.8
mmol/l
0.42
180
1432
132
1022
1.48
2.99
2.4
2.3
81.9
76.4
nmol/l
1.20
120
897
300
2759
1.82
2.93
20.8
15.3
3.9
4.0
mmol/l
1.96
295
2679
95
691
1.52
2.90
2.7
2.4
339.8
7511.7
umol/l
2.96
82
597
7
13
5.47
2.88
1.1
1.6
3.7
4.3
nmol/l
—
7
13
299
2750
1.79
2.88
20.5
15.2
139.3
139.8
mmol/l
2.80
294
2670
7
14
5.08
2.74
1.4
1.4
13.8
16.7
ug/l
—
7
14
48
300
1.70
2.72
5.1
5.8
0.8
1.5
mmol/l
0.49
36
231
7
15
4.74
2.61
1.9
1.9
—
—
—
0
0
43
271
1.67
2.38
2.5
2.2
6.7
6.8
umol/l
0.03
43
232
5
8
6.32
2.38
3.0
1.4
25.6
25.8
u/l
—
5
8
222
1945
1.42
2.35
4.4
4.2
14.0
12.0
mm/h
1.02
198
1776
300
2795
1.68
2.31
22.6
14.7
79.4
79.6
umol/l
0.03
300
2795
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
16
73
2.25
2.25
1.8
2.6
0.3
0.4
u/ml
—
6
39
39
244
1.68
2.22
5.6
6.4
118.6
123.9
g/l
0.91
39
235
9
30
3.05
2.16
1.4
1.5
—
—
—
0
0
113
897
1.39
2.10
2.9
2.9
—
—
—
0
0
26
150
1.79
1.97
1.3
1.6
—
—
—
0
0
38
247
1.61
1.89
3.8
3.0
—
—
—
0
0
55
393
1.48
1.80
1.8
1.7
—
—
—
0
0
13
61
2.18
1.74
1.2
1.6
—
—
—
0
0
297
2799
1.53
1.71
12.9
8.9
25.6
26.3
u/l
0.23
283
2678
106
862
1.34
1.64
2.5
3.0
1102.8
1496.1
ng/l
0.95
91
724
266
2463
1.38
1.63
19.4
11.3
80.2
78.0
ml/min/173m2
1.13
238
1979
6
20
3.04
1.59
1.3
1.1
—
—
—
0
0
6
20
3.04
1.59
1.3
1.1
—
—
—
0
0
254
2339
1.35
1.58
20.9
13.7
38.5
39.9
%
1.52
181
1604
49
353
1.45
1.55
2.8
2.3
2.2
2.3
g/l
0.51
44
330
17
97
1.79
1.37
1.6
1.6
—
—
—
0
0
9
42
2.17
1.34
1.3
1.2
—
—
—
0
0
39
281
1.44
1.26
1.6
1.7
—
—
—
0
0
84
687
1.30
1.23
3.3
2.8
0.4
0.5
e6/l
0.18
68
495
79
646
1.29
1.16
2.0
2.1
2.6
3.2
mg/l
1.35
60
539
34
463
0.70
1.14
1.3
1.3
12.8
44.1
iu/ml
—
10
147
7
31
2.28
1.11
1.1
1.2
—
—
—
0
0
15
89
1.72
1.09
1.8
1.5
—
—
—
0
0
52
406
1.33
1.06
3.1
2.6
1.6
2.3
e6/l
0.40
30
210
43
327
1.36
1.04
3.1
2.4
25.4
23.5
%
0.34
37
284
13
75
1.76
1.04
1.5
1.8
—
—
—
0
0
5
22
2.29
1.03
2.6
1.7
2.7
171.1
u/ml
—
5
22
33
441
0.72
1.00
1.2
1.3
19.8
16.1
u/ml
0.09
11
161
12
69
1.77
0.97
1.5
1.6
—
—
—
0
0
37
279
1.37
0.95
1.6
1.8
—
—
—
0
0
6
28
2.16
0.92
1.3
1.5
—
—
—
0
0
6
29
2.09
0.89
1.0
1.3
—
—
—
0
0
6
29
2.09
0.89
2.2
2.3
—
572.8
—
0
6
6
29
2.09
0.89
1.0
3.2
—
32.9
—
0
8
255
2414
1.23
0.89
5.1
4.6
2.0
2.4
mu/l
0.39
226
2187
212
1973
1.20
0.87
4.3
3.8
14.7
14.9
pmol/l
0.63
191
1779
6
31
1.95
0.85
1.2
1.1
—
4.2
—
0
13
6
32
1.89
0.82
1.0
1.3
—
—
—
0
0
6
34
1.78
0.76
1.3
1.2
—
—
—
0
0
156
1426
1.18
0.75
2.4
2.7
—
—
—
0
0
9
55
1.65
0.74
1.8
1.1
—
—
—
0
0
5
25
2.01
0.73
1.0
1.1
—
—
—
0
0
9
56
1.62
0.73
1.6
1.4
—
—
—
0
0
7
40
1.77
0.71
1.7
1.3
—
—
—
0
0
65
554
1.21
0.68
1.9
1.7
1.8
1.1
mg/l
0.49
52
433
5
95
0.52
0.67
1.2
1.6
—
163.3
—
0
6
52
434
1.23
0.67
2.9
2.4
1.0
1.2
e6/l
0.22
31
237
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
43
354
1.25
0.63
6.1
6.8
—
—
—
0
0
120
1088
1.16
0.62
3.5
3.8
210.4
70.2
ng/l
0.35
85
788
46
382
1.24
0.62
21.0
23.6
1.4
1.3
inr
—
8
55
8
50
1.61
0.61
1.3
1.2
—
—
—
0
0
62
536
1.19
0.57
1.9
1.7
1084.9
1161.2
nmol/l
0.23
45
410
6
37
1.63
0.56
1.0
1.2
—
—
—
0
0
255
2634
0.87
0.49
4.4
4.7
4.6
4.6
mmol/l
0.06
228
2432
91
823
1.14
0.49
4.0
2.2
62.9
58.5
u/l
0.15
84
760
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
8
119
0.66
0.46
1.5
1.3
—
—
—
0
0
5
81
0.61
0.46
2.0
1.7
43.6
41.3
nmol/l
—
5
76
11
77
1.44
0.46
2.5
3.4
—
—
—
0
0
7
51
1.38
0.44
1.1
1.2
—
—
—
0
0
254
2618
0.88
0.44
4.3
4.7
1.5
1.5
mmol/l
0.06
222
2407
10
70
1.44
0.42
2.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
5
34
1.48
0.40
4.6
4.1
313.6
344.5
umol/l
—
5
29
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
8
61
1.32
0.40
2.8
2.5
94.4
89.4
%
—
8
55
5
37
1.36
0.37
1.0
1.1
—
—
—
0
0
76
830
0.89
0.36
3.9
3.7
24.1
24.2
%
0.02
37
370
114
1066
1.11
0.35
3.1
2.6
174.2
134.1
ug/l
0.47
96
978
263
2694
0.89
0.35
4.8
5.3
2.6
2.7
mmol/l
0.33
228
2478
6
43
1.40
0.35
1.2
1.3
—
—
—
0
0
93
1000
0.90
0.34
4.2
3.7
—
—
—
0
0
75
690
1.11
0.32
1.6
1.5
18.7
21.0
nmol/l
0.61
61
588
8
64
1.26
0.27
1.1
1.1
—
23.2
—
0
8
122
1158
1.08
0.27
2.3
2.0
96.1
94.8
pmol/l
0.10
66
606
133
1268
1.08
0.26
3.5
3.6
0.0
0.0
estimate
0.00
19
216
175
1692
1.07
0.23
2.7
3.0
46.9
47.2
u/l
0.01
164
1572
19
162
1.18
0.23
3.9
3.8
1.3
2.1
mmol/l
0.34
12
121
18
153
1.19
0.23
1.6
1.4
—
—
—
0
0
17
144
1.19
0.22
1.6
2.3
1.2
1.2
%
0.06
17
144
5
41
1.22
0.22
1.0
1.6
—
—
—
0
0
16
188
0.84
0.22
1.7
1.9
—
—
—
0
0
12
98
1.23
0.21
1.6
1.7
1.4
1.9
ug/l
0.22
12
86
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
9.1
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
248
2527
0.93
0.21
3.9
4.2
1.2
1.3
mmol/l
1.36
212
2307
11
134
0.81
0.21
1.2
1.3
46.4
217.0
u/ml
3.45
11
124
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
16
187
0.85
0.21
2.0
1.8
—
—
—
0
0
6
49
1.23
0.20
1.3
1.1
25.0
14.3
u/l
—
6
40
19
165
1.16
0.19
1.7
1.6
—
—
—
0
0
49
526
0.92
0.18
1.2
1.2
7.4
1.9
u/ml
—
8
124
5
66
0.75
0.17
1.2
1.2
—
—
—
0
0
15
171
0.87
0.15
1.5
1.8
—
—
—
0
0
56
592
0.94
0.14
1.7
1.8
414.9
24375423.7
pmol/l
0.80
40
480
13
148
0.87
0.12
1.4
3.0
25.0
25.2
mmol/l
0.10
13
143
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
5
60
0.83
0.08
4.4
4.0
36.4
27.5
mg/l
—
5
38
7
64
1.10
0.08
1.4
1.1
—
1.1
—
0
5
6
71
0.84
0.07
1.5
1.2
—
—
—
0
0
6
70
0.85
0.07
1.0
1.3
—
—
—
0
0
8
77
1.04
0.07
1.8
1.7
—
—
—
0
0
57
551
1.04
0.07
4.4
3.8
47.5
233.5
ng/l
1.93
51
438
7
81
0.86
0.07
1.6
1.5
—
—
—
0
0
7
83
0.84
0.07
1.4
1.1
—
—
—
0
0
7
83
0.84
0.07
1.4
1.1
—
—
—
0
0
25
265
0.94
0.07
2.7
3.2
5.7
5.8
kpa
0.16
25
255
264
2621
1.03
0.06
4.3
4.8
6.0
6.0
mmol/l
0.53
234
2368
36
346
1.05
0.05
1.3
1.4
—
—
—
0
0
10
90
1.11
0.05
1.7
2.2
—
—
—
0
0
15
139
1.08
0.05
5.2
2.6
0.7
0.2
e6/l
0.63
15
133
103
1047
0.98
0.05
4.7
3.8
2.1
1.9
ug/l
0.21
88
923
56
571
0.98
0.03
2.8
2.7
0.7
0.7
ug/l
0.34
38
373
10
108
0.92
0.03
1.1
1.0
—
—
—
0
0
70
710
0.98
0.02
1.6
1.7
1.2
1.4
mmol/l
1.64
57
585
19
182
1.05
0.02
5.8
6.1
24.8
24.3
mmol/l
0.40
19
171
69
681
1.02
0.02
3.8
3.8
0.0
0.0
estimate
0.50
19
210
12
127
0.94
0.01
4.2
3.3
23.8
24.5
mmol/l
0.36
12
114
127
1278
0.99
0.01
5.3
5.0
0.0
0.0
estimate
0.50
19
214
36
353
1.02
0.01
4.2
4.9
35.4
32.4
%
0.84
23
229
129
1297
0.99
0.01
3.8
3.7
0.0
0.0
estimate
0.00
19
207
31
308
1.01
0.00
1.6
1.4
—
—
—
0
0
23
225
1.02
0.00
1.7
2.7
4.6
4.5
kpa
0.02
23
213
251
2514
0.99
0.00
5.5
6.4
39.4
40.5
mmol/mol
1.18
223
2326
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
67
0.89
0.00
2.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
6.2
—
70.4
—
0
5
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
0.00
1.7
1.2
—
47.5
—
0
6
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_PAROTIDGLAND_EXALLC – Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).